Deletion of Ppard in CD11c+ cells attenuates atherosclerosis in ApoE knockout mice. Issue 2 (9th January 2020)

• Record Type: Journal Article
• Authors: Tian, Danyang; Hong, Huiling; Shang, Wenbin; Ho, Chin Chung; Dong, Jinghui; Tian, Xiao Yu
• Is Part Of: FASEB journal. Volume 34:Issue 2(2020)
• Page Start: 3367
• Page End: 3378
• Publication Date: 2020-01-09
• Subjects: atherosclerosis -- dendritic cells -- inflammation -- PPARdelta; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.201902069R
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Ppardδ, one of the lipid‐activated nuclear receptor expressed in many cell types to activate gene transcription, also regulates cellular functions other than lipid metabolism. The mechanism regulating the function of antigen‐presenting cells during the development of atherosclerosis is not fully understood. Here we aimed to study the involvement of PPARδ in CD11c + cells in atherosclerosis. We used the Cre‐loxP approach to make conditional deletion of Ppard in CD11c + cells in mice on Apoe –/– background, which were fed with high cholesterol diet to develop atherosclerosis. Ppard deficiency in CD11c + cells attenuated atherosclerotic plaque formation and infiltration of myeloid‐derived dendritic cells (DCs) and T lymphocytes. Reduced lesion was accompanied by reduced activation of dendritic cells, and also a reduction of activation and differentiation of T cells to Th1 cells. In addition, DC migration to lymph node was also attenuated with Ppard deletion. In bone marrow‐derived DCs, Ppard deficiency reduced palmitic acid‐induced upregulation of co‐stimulatory molecules and pro‐inflammatory cytokine IL12 and TNFα. Our results indicated PPARδ activation by fatty acid resulted in the activation of myeloid DCs and subsequent polarization of T lymphocytes, which contributed to atherosclerosis in Apoe –/– mice. These findings also reveal the potential regulatory role of PPARδ in antigen presentation to orchestrate the immune responses during atherosclerosis.